prof. dr. ir. Kathleen Claes
- ORCID iD
- 0000-0003-0841-7372
Show
Sort by
-
Towards improved Parsortix® efficiency for circulating tumor cell enrichment in pancreatic cancer
(2024) -
- Journal Article
- open access
EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer
-
- Journal Article
- open access
The clinical use of exome sequencing to diagnose PCD patients
-
Advances in CRISPR-mediated knock-in of disease-related variants in zebrafish
(2024) -
Advances in CRISPR-mediated knock-in of disease- and cancer-related variants in zebrafish
(2024) -
- Journal Article
- A1
- open access
Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study
-
The psychological impact of genetic testing in childhood cancer : a systematic review
-
Assessing recovery rates of mesenchymal and epithelial pancreatic tumor cells using the Parsortix system
-
- Journal Article
- A1
- open access
A preclinical platform for assessing long-term drug efficacy exploiting mechanically tunable scaffolds colonized by a three-dimensional tumor microenvironment
-
- Journal Article
- A1
- open access
ENIGMA CHEK2gether Project : a comprehensive study identifies functionally impaired CHEK2 germline missense variants associated with increased breast cancer risk